21 related articles for article (PubMed ID: 2422732)
1. Improvement in Blood Supply After "Heparin-Dextran" Therapy in Patients of Buerger's Disease with Critical Limb Ischemia.
Bag S; Behera A; Khandelwal N; Bapuraj JR; Vasishta RK
Indian J Surg; 2013 Dec; 75(6):462-8. PubMed ID: 24465103
[TBL] [Abstract][Full Text] [Related]
2. [Prostaglandin E1 in the treatment of chronic ischemia of the extremities].
Kowal-Gierczak B; Kurzawska-Mielecka M; Czarnacki M
Pol Arch Med Wewn; 1990 Nov; 84(5):321-7. PubMed ID: 2075125
[TBL] [Abstract][Full Text] [Related]
3. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
Seghezzi R; Pedroni G; Borri P
Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
[No Abstract] [Full Text] [Related]
4. The relationship of distal systolic pressures to the clinical and angiographic findings in limbs with arterial occlusive disease.
Lezack JD; Carter SA
Scand J Clin Lab Invest Suppl; 1973; 128():97-101. PubMed ID: 4764607
[No Abstract] [Full Text] [Related]
5. [Evaluation of a single infusion of low-molecular dextran in patients with chronic obliterative arterial diseases].
Chrzanowski W
Pol Tyg Lek; 1969 Jul; 24(27):1057-9. PubMed ID: 4896578
[No Abstract] [Full Text] [Related]
6. [Current diagnostic and therapeutic trends in obliterating arteriopathies: oscillometry and Doppler examination].
De Martiis M; Assogna G; D'Ottavi O; D'Ottavi R; Fontana M
Clin Ter; 1980 Oct; 95(2):115-25. PubMed ID: 7471651
[No Abstract] [Full Text] [Related]
7. [Clinico-pathological aspects of the lower limb ischemia in chronic arterial occlusive disease].
Ito M
Nihon Rinsho; 1999 Jul; 57(7):1620-4. PubMed ID: 10429467
[TBL] [Abstract][Full Text] [Related]
8. Buerger's disease and inflammatory aspects of atherosclerosis.
Lie JT
Curr Opin Rheumatol; 1990 Feb; 2(1):76-80. PubMed ID: 2223460
[No Abstract] [Full Text] [Related]
9. Hypervolemic treatment of the chronic obliterative arteriopathies of extremities.
Brassai Z; Koválszki P; Pop GH; Kiss K; Olosz E
Med Interne; 1986; 24(1):37-41. PubMed ID: 2422732
[TBL] [Abstract][Full Text] [Related]
10. [Antioxidant and metabolic therapy of lower limb chronic obliterative arterial disease].
Koshkin VM; Murav'ev SV; Dadova LV; Kalashov PB
Angiol Sosud Khir; 2006; 12(3):29-32. PubMed ID: 17641611
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
